A Study to Test the Efficacy and Safety of Inhaled TD139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Diseases of the Lung | Diseases of the Respiratory Systems
What is the purpose of this trial?
This is a randomized, double-blind, placebo-controlled phase 2b trial in subjects with IPF (idiopathic pulmonary fibrosis) investigating the efficacy and safety of TD139.
- Ages40 years and older
- Trial withGalecto Biotech AB
- Start Date11/17/2019
- End Date03/30/2021
- Last Updated12/09/2019
- Study HIC#2000025337